Over the last few years, however, Saxagliptin has repeatedly been linked to a number of serious side effects, including anaphylactic shock, acute pancreatitis and upper respiratory tract infection. In 2014, the FDA launched an investigation of the health risks of the drug after receiving reports of higher than normal fatal heart attacks among users. The FDA’s investigation found that individuals who used Onglyza had a 27% higher risk of heart failure than those not using the product. In April, 2016, the FDA issued an additional warning regarding the elevated risk of heart failure for patients using Onglyza.
Onglyza users have also reported alarming rates of pancreatic and thyroid cancer. As a result, the FDA has requested warnings to appear on the drug’s label, referring to the cancer and cardiac risks.
If you or someone you love has suffered injury after taking Onglyza, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory.
Custody decisions are not about rewarding or punishing parents. Courts focus on one question: what arrangement best supp... Read More
Courts don’t approve parenting plans because they look fair to parents. They approve them because the plan clearly pro... Read More
How a worker is classified matters more than many people realize. Being labeled an independent contractor instead of an ... Read More
How It Works